An ozone therapeutic treatment apparatus utilizes magnetism to move the ozone to or across a treatment condition. The treatment condition may be an internal treatment condition and the ozone is implanted into the body by injection or by absorption through the skin. Ozone is diamagnetic, because all of its electrons are paired. The ozone implanted in the body is drawn through the body, across a treatment condition, toward a magnet. The magnet may be a permanent magnet that is placed on or near the skin or may be an electromagnet, wherein the magnetic field is varied as a function of time. The ozone therapeutic treatment apparatus may be used to treat a wide range of conditions including scar tissue in joints, tumors and herpes.

System for gas treatment of cellular implants. The system enhances the viability and function of cellular implants, particularly those with high cellular density, for use in human or veterinary medicine. The system utilizes a miniaturized electrochemical gas generator subsystem that continuously supplies oxygen and/or hydrogen to cells within an implantable and immunoisolated cell containment subsystem to facilitate cell viability and function at high cellular density while minimizing overall implant size. The cell containment subsystem is equipped with features to allow gas delivery through porous tubing or gas-only permeable internal gas compartments within the implantable cell containment subsystem. Furthermore, the gas generator subsystem includes components that allow access to water for electrolysis while implanted, thereby promoting long-term implantability of the gas generator subsystem. An application of the system is a pancreatic islet (or pancreatic islet analogue) implant for treatment of Type 1 diabetes (T1D) that would be considered a bio-artificial pancreas.

A method for generating microbubbles may include providing a syringe having a barrel defining an interior volume, a plunger, a tip and a check valve assembly. The check valve assembly may have an inlet port; a check valve that is configured to open when the plunger is drawn back by a user; and a nozzle in fluid communication with the interior volume and, when the check valve is open, in fluid communication with the inlet port. The method may include drawing liquid into the interior volume; removing a seal from the inlet port and drawing gas adjacent the inlet ports into the interior volume to form microbubbles in the liquid already drawn in; coupling the tip to an intravenous line associated with a patient undergoing a bubble study; and depressing the plunger to force the liquid and the formed microbubbles into the intravenous line.

The present invention comprises methods and devices for generating and providing contrast medium for sonography of structures such as ducts or cavities. The invention provides for creation of a contrast medium comprising detectable acoustic variations between two phases, for example, a gas and a liquid. Sonography is the primary means of imaging but other conventional detection means may also be employed with the present invention.

Methods and devices for diagnosing, monitoring, and/or treating tissue through an opening or port through an airway wall. A passageway is created extending from the airway to the target tissue. The passageway provides local access to the target tissue for treatment instruments and for delivering agents.

Described herein is a multiplex platform that uses ultrasmall nanoparticles (e.g., C dots and C dots) to graphically differentiate specific nerves (e.g., sensory nerves vs. motor nerves) for nerve transplants and other surgeries. Also described herein is a multiplex platform that uses ultrasmall nanoparticles (e.g., C dots and C dots) to graphically differentiate between different types of lymph nodes and/or lymphatic pathways, e.g., to safely and effectively perform vascularized lymph node transplantation in the treatment of lymphedema. Also described herein is a multiplex platform that uses ultrasmall nanoparticles (e.g., C dots and C dots) to graphically differentiate parathyroid tissue.

System for gas treatment of cellular implants. The system enhances the viability and function of cellular implants, particularly those with high cellular density, for use in human or veterinary medicine. The system utilizes a miniaturized electrochemical gas generator subsystem that continuously supplies oxygen and/or hydrogen to cells within an implantable and immunoisolated cell containment subsystem to facilitate cell viability and function at high cellular density while minimizing overall implant size. The cell containment subsystem is equipped with features to allow gas delivery through porous tubing or gas-only permeable internal gas compartments within the implantable cell containment subsystem. Furthermore, the gas generator subsystem includes components that allow access to water for electrolysis while implanted, thereby promoting long-term implantability of the gas generator subsystem. An application of the system is a pancreatic islet (or pancreatic islet analog) implant for treatment of Type 1 diabetes (T1D) that would be considered a bio-artificial pancreas.

A system for a medical system includes a position sensing unit to sense a displacement of a medical device from a medically operational point on a subject, and a signal processing circuit to output, based on the sensed displacement, a signal to disable an alert system when the medical device is for sensing a physiological parameter of a subject during a medical procedure and the displacement is greater than a first threshold value, or to output a signal to enable the alert system when the medical device is for delivering treatment to the subject and the displacement is greater than a second threshold value.

A method for performing a medical procedure requiring effective, reliable and foolproof delivery of controlled amounts of a medical grade gas to a patient includes providing a compressed gas cylinder having a weight with medical grade gas sealed therein of at least twelve grams and not greater than fifty grams. The method also includes connecting the compressed gas cylinder to an integrated compressed gas unit including a regulator valve assembly positioned between an outlet port and an inlet port, wherein the regulator valve assembly includes a press button actuator and regulator adjustment dial. A flow control system is secured to the compressed gas unit and the medical grade gas is delivered in precisely controlled amounts by actuating the compressed gas unit and operating the flow control system to deliver the medical grade gas to vasculature of the patient.

A cardiopulmonary resuscitation system capable of performing passive oxygen administration with reduced oxygen consumption as compared with a conventional passive oxygen administration method. A cardiopulmonary resuscitation system which includes: a sternum compression unit that repeats a sternum compression cycle having, as one cycle, a compression period and a recoil period; an artificial respiration unit that repeats an artificial respiration cycle having, as one cycle, an inhalation period and an exhalation period and can supply oxygen administering gas to a patient during the recoil period; and a control means (not illustrated) that controls the artificial respiration unit and/or the sternum compression unit, and the controller judges, for each recoil period, whether supply of oxygen administering gas is required and sends a supply instruction signal to administer oxygen administering gas to the artificial respiration means unless it is judged that supply of the oxygen administering gas is not required.